Citation Impact
Citing Papers
High-throughput characterization of protein–protein interactions by reprogramming yeast mating
2017 StandoutNobel
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
2003
Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
2011
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors
2017
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
2013
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
2015
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
2008
HER2Gene Amplification in Breast Cancer
2012
Immunotherapy of cancer in 2012
2012
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
EGFR associated expression profiles vary with breast tumor subtype
2007
Triple-Negative Breast Cancer
2010 Standout
Cancer statistics, 2017
2017 Standout
Cancer statistics, 2018
2018 Standout
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer
2016
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Changing Concepts of Hormone Receptor–Positive Advanced Breast Cancer Therapy
2012
Swords into plowshares: IL-23 repurposes tumor immune surveillance
2007
The complex interaction between obesity, metabolic syndrome and reproductive axis: A narrative review
2012
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
2008
Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)
2015
Obesity, adipocytokines, and insulin resistance in breast cancer
2004
Prognostic significance of autoimmunity during treatment of melanoma with interferon
2011
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
2012 StandoutNature
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Global cancer statistics
2011 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Immunity, Inflammation, and Cancer
2010 Standout
Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas
1998
Epidemiology — identifying the causes and preventability of cancer?
2005
Serological identification of breast cancer-related antigens from aSaccharomyces cerevisiae surface display library
2005
Molecular portraits of human breast tumours
2000 StandoutNature
Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle
1993
Cancer immunotherapy comes of age
2011 StandoutNature
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Gastric cancer
2020 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
What We Talk About When We Talk About Fat
2014 Standout
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Clonal evolution in cancer
2012 StandoutNature
Production and Actions of Estrogens
2002 Standout
Palbociclib and Letrozole in Advanced Breast Cancer
2016 Standout
The PI3K Pathway in Human Disease
2017 Standout
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Multiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice
2004 StandoutNobel
‘Genetic heterogeneity' in HER2/neu testing by fluorescence in situ hybridization: a study of 2522 cases
2012
Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal Women
2006 Standout
Tumor Angiogenesis
2008 Standout
Brain Tumors
2001 Standout
The phosphoinositide 3-kinase pathway and therapy resistance in cancer
2015
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance Research
2011
Nanomaterials for In Vivo Imaging
2017
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
2012 StandoutNobel
Durable Complete Responses With High-Dose Bolus Interleukin-2 in Patients With Metastatic Melanoma Who Have Experienced Progression After Biochemotherapy
2007
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers
2015
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
2011
Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials.
2010
Cancer statistics, 2016
2016 Standout
Toxicities of Immunotherapy for the Practitioner
2015
Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/− Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
2009
Immune and molecular correlates in melanoma treated with immune checkpoint blockade
2017
Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade
2007
Cancer Genome Landscapes
2013 StandoutScience
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Immune Regulation of Cancer
2010
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Selective Depletion of Foxp3+ Regulatory T Cells Improves Effective Therapeutic Vaccination against Established Melanoma
2010
Cell-intrinsic role for IFN-α–STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response
2011
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia
2007
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab
2015
Global cancer statistics, 2012
2015 Standout
Immune Therapy for Cancer
2008
Interferons, immunity and cancer immunoediting
2006
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
2016 StandoutNobel
Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
2003
Works of Christos Markopoulos being referenced
Missed cancers on mammograms: causes and measures of prevention.
2004
Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon
2006
Minimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trials
2010
Relationship of epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and vimentin expression and various prognostic factors in breast cancer patients
1995
Mitoxantrone Plus Vinorelbine in Pretreated Patients with Metastatic Breast Cancer
2007
Adiponectin and Breast Cancer Risk
2004
Association of breast cancer with meningioma
1998
Leptin and insulin growth factor I in relation to breast cancer (Greece)
2000
Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle
1988
Association Between Age at Diagnosis and Disease-Specific Mortality Among Postmenopausal Women With Hormone Receptor–Positive Breast Cancer
2012
Correlation of molecular human leukocyte antigen typing and outcome in high‐risk melanoma patients receiving adjuvant interferon
2010
The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc99 and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies
2016
High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas
2002
HeterogeneousHER2Gene Amplification
2011
Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study
2014
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group
2005
Alterations of p16-pRb Pathway and Chromosome Locus 9p21–22 in Sporadic Invasive Breast Carcinomas
1998
The prognostic value of alpha-thymosins in breast cancer.
1998
Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial
2011